RecruitingNot Applicable

Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

Canada1,500 participantsStarted 2025-06-10

Plain-language summary

Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (\>=18 years of age) * Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025 * Identified in the institutional procedure database Exclusion Criteria: * Incomplete or non-available data on the post-procedural clinical follow-up * Procedures where other devices were used in combination with drug-eluting balloons.

What they're measuring

Major Adverse Cardiovascular Events

Timeframe: within 10 years of inclusion

Trial details

NCT IDNCT06972225

SponsorOlivier F. Bertrand

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2035-12

Contact for this trial

Michele Jadin

418-6568711 michele.jadin@criucpq.ulaval.ca

View on ClinicalTrials.gov More Coronary Arterial Disease (CAD) trials